November 12, 2021
A new paper in the journal Ethics and Human Research co-authored by Berkeley Public Health Professor of Bioethics and Medical Humanities Jodi Halpern and Lecturer Sharon E. O’Hara, among others, explores how scientists perceive the potential of CRISPR technology and how the transition of many researchers from bench science (making new discoveries in the lab) to translational science (using these new discoveries to create novel medical treatments) may affect the treatment of those with genetic conditions.
School of Public Affairs